APADAZ
- Product NDC
- 10702-341
- 11-digit product format
- 107020341
- Labeler code
- 10702
- Product ID
- 10702-341_bd5dd034-4b41-2f37-e053-2995a90a4f77
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Benzhydrocodone and Acetaminophen
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- KVK-Tech, Inc.
- Application
- NDA208653
- Marketing category
- NDA
- Marketing start
- 2019-06-28
- Marketing end
- 0000-00-00
- Substance
- BENZHYDROCODONE HYDROCHLORIDE; ACETAMINOPHEN
- Active strength
- 6 mg/1; mg/1
- DEA schedule
- CII
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10702-341 | APADAZ (BENZHYDROCODONE AND ACETAMINOPHEN) TABLET [KVK-TECH, INC.] | 4 | Legacy NDC | 20210313_3a790a49-df42-4577-914c-6ee07a40b60f.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 10702-341-01 | 10702034101 | 100 TABLET in 1 BOTTLE, PLASTIC (10702-341-01) | 100 tablet | 2019-06-28 | 0000-00-00 | No | No | Current |